Isolated native non-rheumatic fungal tricuspid valve endocarditis is rarely described in the absence of intravenous drug addiction or use of intracardiac catheters or concomitant cardiac anomalies. Herein, we report a case of tricuspid valve endocarditis in a non-addict, which was successfully treated with valve replacement. The cultures of blood and vegetations revealed Candida Pichia Etschelsii. Candida tricuspid endocarditis must be considered in any patient with tricuspid vegetation, regardless of predisposing factors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF01616344 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An unusual case of endocarditis of the native tricuspid valve secondary to a tunneled dialysis catheter.
Arch Peru Cardiol Cir Cardiovasc
September 2023
Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia. Lima, Peru. Universidad Peruana Cayetano Heredia Facultad de Medicina Alberto Hurtado Universidad Peruana Cayetano Heredia Lima Peru.
endocarditis is a severe disease associated with high mortality rates. is frequently identified as the causative pathogen in intravenous drug users and is commonly associated with nosocomial infections, primarily due to its ability to form biofilms on catheters or other foreign bodies. Here, we present a rare case of endocarditis affecting the native tricuspid valve in a 35-year-old male patient with end-stage chronic kidney disease (Stage V), who had a suspected fungal infection related to the left cervical catheter.
View Article and Find Full Text PDFIllicit drugs, especially those injected intravenously, are becoming increasingly more common worldwide. Individuals who use intravenous drugs often reuse or share needles which predisposes them to life-threatening infections. We present the case of a patient who was injecting intravenous drugs into her internal jugular vein, which eventually led to acutely worsening sepsis secondary to fungal infective endocarditis and bilateral septic pulmonary emboli.
View Article and Find Full Text PDFDoes Heart Failure Mask Candida Tricuspid Endocarditis?
Cureus
May 2023
Cardiology, St. Joseph's University Medical Center, Paterson, USA.
Infective endocarditis (IE) carries high morbidity and mortality. Although minimal in incidence, fungal causes (mostly species) carry the highest mortality among all cases of infective endocarditis. We describe a rare case of a 47-year-old male with a past medical history of cerebral vascular accident (CVA), heart failure with reduced ejection fraction status post (SP) automated implantable cardioverter defibrillator (AICD) placement, paroxysmal atrial fibrillation, coronary artery disease (CAD), infective endocarditis with mitral valve replacement and tricuspid valve replacement, and pulmonary hypertension who presented to the emergency department (ED) with complaints of shortness of breath and weakness for four days.
View Article and Find Full Text PDFCandid and Fragile: A Case Report of Infective Endocarditis From Candida albicans and Bacteroides fragilis.
Cureus
February 2023
Internal Medicine, NEA Baptist Memorial Hospital, Jonesboro, USA.
Infective endocarditis (IE) remains a significant cause of mortality worldwide and reported cases are continuing to increase annually. We describe a case of a patient who would undergo coronary artery bypass grafting (CABG) with bioprosthetic aortic valve replacement complicated by postop gastrointestinal bleeding requiring partial colectomy with ileocolic anastomosis who would later present with fever, dyspnea, and persistently positive blood cultures who would be found to have tricuspid valve endocarditis from and species that was successfully treated with a combination of surgical resection and antimicrobial therapy.
View Article and Find Full Text PDFPercutaneous debulking of tricuspid valve endocarditis in severe COVID-19 pneumonia after prolonged venovenous extracorporeal membrane oxygenation with right-ventricular support: a case series.
Eur Heart J Case Rep
February 2023
Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Tinsley Harrison Tower, Suite 311, 1900 University Boulevard, Birmingham, AL 35233, USA.
Background: Over the past 2 years, the utilization of venovenous extracorporeal membrane oxygenation (VV-ECMO) for the treatment of coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) has increased. While supporting respiratory function, VV-ECMO requires large-bore indwelling venous cannulas, which risk bleeding and infections, including endocarditis.
Case Summary: We describe two adults hospitalized for COVID-19 pneumonia who developed ARDS and right-ventricular failure, requiring VV-ECMO and ProtekDuo cannulation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!